WP4 Objectives:
- Disseminate and communicate any information concerning the project, results and findings to stakeholders
- Engage with stakeholders to:
- Maximise the probability of rapid market adoption across Europe and identify early adopters
- Secure additional funding or investment to conduct further studies to strengthen and expand the P1vital® PReDicT Test market
- Attract commercial collaborations to increase global market penetration
WP4 Lead: Dr Amy Bilderbeck
WP4 Partners:
- WP2 study investigators to facilitate communication within each country
News:
Oxford University article talks about PReDicT Clinical Study
Oxford University article talks about PReDicT Project run by P1vital Products Limited and P1vital® PReDicT Test which is being used in clinical study across 5 European countries: France, Germany, Spain, The Netherlands and the UK.
To read the full article, click here.
NHS Foundation Trust discusses PReDicT Project
Oxford Health NHS Foundation Trust about PReDicT Project discusses P1vital Products Limited and P1vital® PReDicT Test which is being used in clinical study across 5 European countries.
To read the full article, click here.